Dr Reddy's launches Supanac 50 mg tab in India
Dr Reddy’s Laboratories has launched Supanac-Diclofenac potassium immediate release 50 mg tablets in India.
By INDIATIMES NEWS NETWORK |
MUMBAI: Dr Reddy’s Laboratories has launched Supanac-Diclofenac potassium immediate release 50 mg tablets in India.
Supanac is in-licensed from Applied Pharma Research, Switzerland and is used for acute pain management. This patented product has been developed by Dynamic Buffered Technology making it a superior formulation of Diclofenac, which reaches peak plasma concentration four times faster than Diclofenac enteric coated preparations thereby ensuring faster pain relief.
On Wednesday, Dr Reddy shares ended up 1.01 per cent at Rs 679.95 on BSE.
Supanac is in-licensed from Applied Pharma Research, Switzerland and is used for acute pain management. This patented product has been developed by Dynamic Buffered Technology making it a superior formulation of Diclofenac, which reaches peak plasma concentration four times faster than Diclofenac enteric coated preparations thereby ensuring faster pain relief.
On Wednesday, Dr Reddy shares ended up 1.01 per cent at Rs 679.95 on BSE.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
